Lu W, Chen L. Re: Ipilimumab and Nivolumab Followed by Chemoradiotherapy as Bladder-sparing Treatment in Muscle-invasive Bladder Cancer: A Phase 2 Trial. Eur Urol 2026 Apr 23:S0302-2838(26)02098-1. doi: 10.1016/j.eururo.2026.
PMID: 42031581